By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Shortage of Leukemia Drug Will Result in Deaths
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Shortage of Leukemia Drug Will Result in Deaths
Business

Shortage of Leukemia Drug Will Result in Deaths

BarbaraDuck
BarbaraDuck
Share
2 Min Read
SHARE

There is no alternative treatment to be used for the drug. Oncologists across the country are concerned and some of the hospitals that are turning patients away or having scarce supplies include the City of Hope, Cedars Sinai, Johns Hopkins and Massachusetts General Hospital. There’s quite a number on the list. Injectable drugs seem to be the main target of shortages and even with generics they are expensive to produce and don’t yield any profit, so companies stop making them. When you think of Propofol, the most heavily used drug for anesthesia with surgery, last year we went from 2 US manufacturers to none and it all comes from Germany now. BD

So far, oncologists in 30 states have reported a shortage of cytarabine, a drug that is key to treating certain types of leukemia. The situation, doctors say, is dire. “If we can’t get the drug, then the patients are going to die,” said Dr. Hagop Kantarjian, chairman of the Department of Leukemia at the University of Texas M.D. Anderson Cancer Center in Houston. For patients with AML who take cytarabine, the drug is the difference between a shot at life and certain death. “Since its introduction, we can claim cures in 40 to 50 percent of patients,” said Kantarjian. “Without the drug in the treatment regimen, the rate is zero.” Johns Hopkins Hospital in Baltimore said it only had a two-week supply. “We are really worried if we get a new patient with AML — that will be very hard to keep up with.”

Shortage of Leukemia Drug Cytarabine Forcing Hospitals to Turn Away Patients – ABC News

TAGGED:health care businessleukemia
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

Healthcare Predictions for 2013

January 7, 2013
Image
BusinessHospital Administration

A “Bundle” of New Learning Resources for Health Care Providers

July 3, 2013
independent review organization, Iros, benefits, healthcare
Business

The Top 7 Benefits of External IROs

September 15, 2015

Why Massachusetts Can Afford Universal Health Insurance

December 13, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?